Global Markets
Home›Global Markets›China›Big Pharma expands China innovation deals as patent cl…
Big Pharma expands China innovation deals as patent cliff nears
CNBC World reports that Western biopharma companies are increasingly turning to China to source innovation as the industry’s “patent cliff” approaches.
The outlet says the trend is reflected in a new tie-up valued at up to $7.8 billion, as deal activity in China continues to grow.
← Newer storyU.S. employment report shows jobs gain slows to 29,000 in SeptemberOlder story →Investors weigh longer-dated duration despite turbulent bond markets
More like this
Global MarketsCXMT makes progress on new memory chip designs
Global MarketsChina Mobile triples capacity at Hohhot AI computing hub